News & Trends - Pharmaceuticals
Transparency at a new level with MA’s centralised reporting system
Medicines Australia is pleased to announce the launch of a Centralised Reporting System available at www.DisclosureAustralia.com.au
The system will make it simpler than ever to understand interactions between pharmaceutical companies and healthcare professionals.
The system went live on Friday 30 August 2019 and will contain all information that was previously available through an individual company’s website, in an easily searchable form.
Medicines Australia CEO, Elizabeth de Somer thanked member companies for their support of the initiative.
“The Code of Conduct is already one of the best forms of a self-regulatory practice here in Australia, and has been since it was introduced almost 60 years ago,” said Ms de Somer.
“We are taking our already rigorous transparency model to the next level by providing a platform that’s easy to use and accessible to all.
“We are proud of the important role we play in educating medical professionals about the latest in innovative therapies.
“Our members provide clear information about payments to a healthcare professional so they can access the latest educational opportunities, attend conferences or symposia, or for their services as an expert.
“By supporting ongoing education, companies can assist healthcare professionals to acquire the appropriate understanding and knowledge of new innovative therapies, which is appropriate and accountable,” concluded Ms de Somer.
News & Trends - Pharmaceuticals
Government inaction on mental illness faces overwhelming criticism ahead of federal election
Pharma News: The Federal Government must strengthen its support for individuals with severe and complex mental illness to prevent future […]
MoreNews & Trends - Pharmaceuticals
New CVD model marks a critical step in the right direction
Pharma News: Cardiovascular disease (CVD) affects four million Australians and claims one life every 12 minutes. A recent heart screening […]
MoreNews & Trends - Pharmaceuticals
Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation
Pharma News: A newly commissioned report by Lilly, unveiled at Parliament House, has shed light on the health, societal, and […]
MoreLeadership & Management
J&J MedTech appoints new ANZ leader
Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and […]
More